Inadvertent intramuscular injection risk with subcutaneous insulin injections and risk predictors in adults: a cross-sectional sonographic study

ConclusionsThere is a high inadvertent intramuscular injection risk with currently used needles (8 and 13  mm) with U-100 syringes in our population even with a raised skin fold. To minimize this risk, 13-mm needles should be avoided when injecting insulin subcutaneously especially to the limbs. Sex and anthropometric parameters can be used to predict the distance from skin to muscle surface; hence, th e selection of needle length could be personalized based on the derived formulae.
Source: International Journal of Diabetes in Developing Countries - Category: Endocrinology Source Type: research